Calix[4]arene-25,26,27,28-tetrol

Suppliers

Names

[ CAS No. ]:
74568-07-3

[ Name ]:
Calix[4]arene-25,26,27,28-tetrol

[Synonym ]:
MFCD00143912
Calix[4]arene-25,26,27,28-tetrol
pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaene-25,26,27,28-tetrol
Tetrahydroxycalix[4]arene
Pentacyclo[19.3.1.1.1.1]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-25,26,27,28-tetrol
25,26,27,28-Tetrahydroxycalix[4]aren
Pentacyclo[19.3.1.1.1.1]octacosa-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaene-25,26,27,28-tetrol
Pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-25,26,27,28-tetrol

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
598.5±50.0 °C at 760 mmHg

[ Melting Point ]:
315-318ºC

[ Molecular Formula ]:
C28H24O4

[ Molecular Weight ]:
424.488

[ Flash Point ]:
264.9±24.7 °C

[ Exact Mass ]:
424.167450

[ PSA ]:
80.92000

[ LogP ]:
5.37

[ Appearance of Characters ]:
Crystalline Powder | Off-white to light beige

[ Vapour Pressure ]:
0.0±1.8 mmHg at 25°C

[ Index of Refraction ]:
1.689

[ Storage condition ]:
2~8℃

[ Water Solubility ]:
Soluble in chloroform.

MSDS

Safety Information

[ Hazard Codes ]:
Xi:Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S37/39

[ WGK Germany ]:
3


Related Compounds

  • calix[4]arene-25,26,27,28-tetrol
  • Calix[4]quinone
  • p-Chloromethyl-methoxy-calix[4]arene
  • 4-sulfocalix[4]arene sodium salt
  • 4-tert-butyl-calix[4]arene tetra-n-propyl ether
  • 5-bromo-25,26,27,28-tetrakis(1-propyloxy)calix(4)arene
  • 1H-Furo[3,4-c]pyrrole-5(3H)-carboxylic acid, 3a-fluorotetrahydro-, 1,1-dimethylethyl ester, (3aR,6aR)-rel-
  • 2,6-Pyridinediamine, N2-(trans-4-aminocyclohexyl)-N6-(6-bromo-2-benzothiazolyl)-4-(1H-pyrazol-1-ylmethyl)-
  • 1,1-Dimethylethyl 1-(2-cyclohexen-1-yl)-1,4,6,7-tetrahydro-3-oxoisoxazolo[4,3-c]pyridine-5(3H)-carboxylate
  • 9-Octadecenoic acid, 17-[(2-O-I(2)-D-glucopyranosyl-I(2)-D-glucopyranosyl)oxy]-, intramol. 1,6a(2)-ester, (9Z,17R)-
  • 4-(1,1-Dimethylethyl)-N-[5-(2-ethoxyphenoxy)-6-(2-hydroxyethoxy)[2,2a(2)-bipyrimidin]-4-yl]benzenesulfonamide
  • 3-Chloro-4-[methyl[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzisoxazol-6-yl]oxy]propyl]amino]benzenemethanol
  • rel-(1R,2S,3R,5R,6S,7R)-Tetrahydro-3,7-diphenyl-1H,5H-pyrazolo[1,2-a]pyrazole-1,2,5,6-tetracarboxylic acid
  • Glycine, N-[[3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,5-dioxo-1-pyrrolidinyl]acetyl]-, methyl ester, (S)-
  • Piperidine, 2,3,4,5-tetrakis[(trimethylsilyl)oxy]-6-[[(trimethylsilyl)oxy]methyl]-, [2R-(2I+/-,3I+/-,4I(2),5I+/-,6I(2))]-
  • 1-Piperidinecarboxamide, N-[2-(5-chloro-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]-4-(hydroxymethyl)-4-methyl-